AMZN
Amazon.com, Inc.
AMZN has the edge over WEN overall, supported by stronger modeled upside and lower modeled downside.
WEN
The Wendy's Company
WEN trails on the overall score without a compensating advantage in the available component scores.
AMZN Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Weak | |
| Healthy |
AMZN's revenue, profitability and balance sheet are currently healthy, but its cash flow is weak.
WEN Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Healthy | |
| Weak |
WEN's cash flow is currently healthy, and its revenue and profitability are stable, but its balance sheet is weak.
AMZN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 22x | $267 | — |
| Forward | 27x | $267 | — |
| Cheap | 34x | $415 | +55% |
| Fair | 60x | $745 | +179% |
| Expensive | 102x | $1,262 | +372% |
Historical ranges are pointers, not guarantees.
AMZN has the edge over WEN in the historical PE scenario, which offers more potential upside but is not a forecast.
WEN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 11x | $5.76 | -30% |
| Current | 16x | $8.18 | — |
| Fair | 23x | $11.48 | +40% |
| Expensive | 39x | $19.70 | +141% |
Historical ranges are pointers, not guarantees.
WEN's PE is in its cheap range at 16x.
AMZN Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Strong growth | |
| Growth | |
| Improving | |
| Moderate | |
| Moderate |
Analysts expect earnings and revenue growth for AMZN, with profitability improving.
WEN Forward outlook
There aren't enough analyst estimates for WEN to show an outlook.
AMZN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $9.87 | -20% |
| Q3 2026 | $12.37 | +75% |
| Q2 2026 | $12.43 | +89% |
| Q1 2026 | $8.36 | +36% |
| Q4 2025 | $7.17 | +30% |
| Q3 2025 | $7.08 | +52% |
| Q2 2025 | $6.56 | +57% |
| Q1 2025 | $6.14 | +72% |
| Q4 2024 | $5.53 | +91% |
AMZN has the edge over WEN on earnings, with more consistent year-over-year improvement.
WEN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $0.51 | -46% |
| Q2 2026 | $0.66 | -31% |
| Q1 2026 | $0.78 | -17% |
| Q4 2025 | $0.85 | -11% |
| Q3 2025 | $0.94 | 0% |
| Q2 2025 | $0.96 | -1% |
| Q1 2025 | $0.94 | -4.1% |
| Q4 2024 | $0.95 | -2.1% |
WEN's earnings per share have fallen from their peak: $0.51 over the past year, against $0.98 in early 2024.
AMZN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $201.9B | +12% |
| Q2 2026 | $200.6B | +20% |
| Q1 2026 | $181.5B | +17% |
| Q4 2025 | $213.4B | +14% |
| Q3 2025 | $180.2B | +13% |
| Q2 2025 | $167.7B | +13% |
| Q1 2025 | $155.7B | +8.6% |
| Q4 2024 | $187.8B | +10% |
AMZN has the edge over WEN on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 14% | +4.2 points |
| Q2 2026 | 14% | +2.3 points |
| Q1 2026 | 13% | +1.3 points |
| Q4 2025 | 12% | +0.4 points |
| Q3 2025 | 9.7% | -1.3 points |
| Q2 2025 | 11% | +1.5 points |
| Q1 2025 | 12% | +1.1 points |
| Q4 2024 | 11% | +3.5 points |
AMZN has the edge over WEN on profitability, with a higher operating margin.
WEN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $547M | -0.5% |
| Q2 2026 | $570.6M | +1.7% |
| Q1 2026 | $540.6M | +3.3% |
| Q4 2025 | $543M | -5.5% |
| Q3 2025 | $549.5M | -3% |
| Q2 2025 | $560.9M | -1.7% |
| Q1 2025 | $523.5M | -2.1% |
| Q4 2024 | $574.3M | +6.2% |
WEN's revenue grew through 2022 and has held roughly level since: $547M last quarter, about level with the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 10% | -6.6 points |
| Q2 2026 | 14% | -4.7 points |
| Q1 2026 | 12% | -3.9 points |
| Q4 2025 | 12% | -4.9 points |
| Q3 2025 | 17% | 0 points |
| Q2 2025 | 19% | +1.1 points |
| Q1 2025 | 16% | +0.7 points |
| Q4 2024 | 17% | +0.7 points |
WEN's operating margin was 10% last quarter, down 6.6 points from the same quarter a year ago, near the bottom of its range since 2019.
AMZN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$34.8B | -8202% |
| Q2 2026 | -$8.8B | -2757% |
| Q1 2026 | -$18.2B | -$10.2B |
| Q4 2025 | $14.9B | -16% |
| Q3 2025 | $430M | -87% |
| Q2 2025 | $332M | -96% |
| Q1 2025 | -$8B | -297% |
| Q4 2024 | $17.8B | -36% |
AMZN's free cash flow was −$46.9B over the past year, against $10.6B the year before.
WEN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $61.7M | -41% |
| Q2 2026 | $81M | +107% |
| Q1 2026 | $47.5M | -30% |
| Q4 2025 | $31.4M | +18% |
| Q3 2025 | $104.3M | -15% |
| Q2 2025 | $39.2M | +38% |
| Q1 2025 | $67.7M | -18% |
| Q4 2024 | $26.6M | -43% |
WEN has the edge over AMZN on cash generation, producing positive trailing cash flow while its opponent burns cash.
AMZN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +26M shares |
| 1 year | +0.8% | +84M shares |
| 3 years | +3.5% | +371M shares |
| 5 years | +6.1% | +629M shares |
| Available history | +8.2% | +829M shares |
AMZN has 10.9B diluted shares, up 0.8% from a year ago.
| Quarter | Spent |
|---|---|
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
| Q1 2023 | — |
| Q4 2022 | — |
| Q3 2022 | — |
| Q2 2022 | $3.3B |
WEN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.3% | +589K shares |
| 1 year | +0.3% | +548K shares |
| 3 years | -8.9% | -18.8M shares |
| 5 years | -15% | -33.3M shares |
| Available history | -18% | -43.3M shares |
WEN has the edge over AMZN on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | $1.9M |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | $14.3M |
| Q2 2025 | $63.7M |
| Q1 2025 | $122.8M |
| Q4 2024 | $17.3M |
WEN spent $2M buying back its own shares over the past year, down 99% from the year before.
AMZN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.7x | Very low |
| Q2 2026 | 0.3x | Very low |
| Q1 2026 | 0.1x | Very low |
| Q4 2025 | -0.1x | Net Cash |
| Q3 2025 | -0.1x | Net Cash |
| Q2 2025 | -0.0x | Net Cash |
| Q1 2025 | -0.1x | Net Cash |
| Q4 2024 | -0.2x | Net Cash |
AMZN has the edge over WEN on leverage, with a lower net debt burden relative to earnings.
WEN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 5.6x | High |
| Q2 2026 | 5.3x | High |
| Q1 2026 | 5.1x | High |
| Q4 2025 | 5.0x | High |
| Q3 2025 | 4.7x | High |
| Q2 2025 | 4.7x | High |
| Q1 2025 | 4.6x | High |
| Q4 2024 | 4.5x | High |
WEN's net debt is about 5.6 years of its operating earnings (EBITDA), up from 4.7 years a year ago.
AMZN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 57.1 | Neutral |
| Stochastic | 50.0 | Neutral |
AMZN's weekly RSI is 57 (neutral) and its Stochastic is 50 (neutral).
WEN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 55.9 | Neutral |
| Stochastic | 59.6 | Neutral |
WEN's weekly RSI is 56 (neutral) and its Stochastic is 60 (neutral).
AMZN PE vs Consumer Cyclical Sector
| Metric | AMZN | Sector median | Relative |
|---|---|---|---|
| PE | 22x | 18x | 20% above |
| PE % | 4 | 47 | 43 pts below |
AMZN is trading at 22x earnings, a 20% premium to the Consumer Cyclical sector's median of 18x, though its recent earnings include one-off gains.
WEN PE vs Consumer Cyclical Sector
| Metric | WEN | Sector median | Relative |
|---|---|---|---|
| PE | 16x | 18x | 11% below |
| PE % | 25 | 47 | 22 pts below |
WEN has the edge over AMZN on valuation relative to its sector.
AMZN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $253.6 | 5.5% above |
| 20 week MA | $254.9 | 4.9% above |
| 50 week MA | $242.5 | 10% above |
| 100 week MA | $229.6 | 17% above |
| 200 week MA | $191.4 | 40% above |
AMZN has the edge over WEN on trend strength, trading above more of its moving averages.
WEN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $6.92 | 18% above |
| 20 week MA | $7.48 | 9.4% above |
| 50 week MA | $7.56 | 8.2% above |
| 100 week MA | $9.77 | 16% below |
| 200 week MA | $14.7 | 44% below |
WEN has bounced recently, but its long-term trend is still down: it's above its 8-, 20- and 50-week averages, but 44% below its 200-week average.
AMZN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $93.5 | $158.6 | +70% |
| 2021 | $158.6 | $171.1 | +7.8% |
| 2022 | $171.1 | $85.3 | -50% |
| 2023 | $85.3 | $151.9 | +78% |
| 2024 | $151.9 | $223.8 | +47% |
| 2025 | $223.8 | $232.5 | +3.9% |
| 2026 YTD | $232.5 | $267.4 | +15% |
AMZN has the edge over WEN on returns for 2026, with the stronger performance.
WEN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $22.2 | $22.5 | +1.3% |
| 2021 | $22.5 | $23.3 | +3.9% |
| 2022 | $23.3 | $23.1 | -0.9% |
| 2023 | $23.1 | $19.5 | -16% |
| 2024 | $19.5 | $16.5 | -15% |
| 2025 | $16.5 | $8.35 | -49% |
| 2026 YTD | $8.35 | $8.18 | -2% |
WEN has finished four years in a row lower, and it's down 2% so far in 2026.